Agilent Technologies, Inc. A

NYSE · Healthcare · Medical - Diagnostics & Research

$170.38

Close on Fri, 20 Nov 2026 · market value $48B

What the price is betting on

Priced for a lot to go right

At $170, the price assumes revenue grows about 20% a year for five years, from $7.4B to about $15.8B by FY2030. That is about three times what analysts expect for the next two years and about seven times the company's own last three years.

The price assumes20%
Analysts, next two years6.6%
Last 3 years2.8%

Revenue growth a year. The price figure comes from a reverse DCF at a 9.8% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than A? Check up to 5 of your stocks at once, free, no account.

0$5B$10B$15B$20B$7.4B'22'23'24'25Jul '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$77

Base

$88

Bull

$100

Today $170

  • Bear $77. Cash flow grows 4% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $88. Cash flow grows 7% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $100. Cash flow grows 9% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$7.7B$7.5B, on the path
  3. FY2027$9.2B$8B, below the path
  4. FY2028$11B$8.5B, below the path
  5. FY2029$13.2B$9.1B, below the path
  6. FY2030$15.8B$9.4B, below the path

Each year's revenue at 20% growth from $7.4B in the 12 months to July 2026.

At a glance

Healthcare · Medical - Diagnostics & Research · listed on NYSE

Revenue, FY2025
$6.9B
Growth, 3 years a year
2.8%
Cash margin
17%
Net debt
$1.6B
Shares, 3-year change
−5.3%
Dividend yield
0.6%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.